1. The Analysis of PTPN6 for Bladder Cancer: An Exploratory Study Based on TCGA
   Chengquan Shen et al, 2020, Disease Markers CrossRef
2. A Transcriptional Signature of IL-2 Expanded Natural Killer Cells Predicts More Favorable Prognosis in Bladder Cancer
   Yuhan Sun et al, 2021, Frontiers in Immunology CrossRef
3. Herpesvirus entry mediator as a potential biomarker in breast cancer compared with conventional cytotoxic T‑lymphocyte‑associated antigen 4
   Alia Aldahlawi et al, 2023, Biomedical Reports CrossRef
4. Cuproptosis correlates with immunosuppressive tumor microenvironment based on pan-cancer multiomics and single-cell sequencing analysis
   Yan Qin et al, 2023, Molecular Cancer CrossRef
5. The role of costimulatory molecules in glioma biology and immune microenvironment
   Ji Wang et al, 2022, Frontiers in Genetics CrossRef
6. Identification of a Prognosis-Related Risk Signature for Bladder Cancer to Predict Survival and Immune Landscapes
   Linhui Wang et al, 2021, Journal of Immunology Research CrossRef
7. Single-Cell Sequencing Unveils the Heterogeneity of Nonimmune Cells in Chronic Apical Periodontitis
   Xinwei Lin et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
8. Identification of Immune-Related Genes Associated With Bladder Cancer Based on Immunological Characteristics and Their Correlation With the Prognosis
   Zhen Kang et al, 2021, Frontiers in Genetics CrossRef
9. The Pyroptosis-Related Risk Genes APOBEC3D, TNFRSF14, and RAC2 Were Used to Evaluate Prognosis and as Tumor Suppressor Genes in Breast Cancer
   Qian Chen et al, 2022, Journal of Oncology CrossRef